Authors


Sunil Mamtora, MD

Latest:

A portable solution for high-definition slit lamp imaging

TAKE-HOME: This affordable device allows the view through a slit lamp to be shared in real time or recorded, for teaching and reference purposes.


Peter Mortensen, MD

Latest:

Investigators research ocular health after space flight

Spaceflight-associated neuro-ocular syndrome a potential challenge during long missions.


David M. Brown, MD

Latest:

Future of Intravitreal Injection

Nadia K. Waheed, MD, MPH, and David M. Brown, MD, discuss the future of intravitreal injections.


David R. Lally, MD

Latest:

Final Thoughts on Case Presentations and Advanced Therapies

Retinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.


Omar R. Shakir, MD, MBA

Latest:

Advances in Phacoemulsification Techniques

A panelist discusses how different phacoemulsification technologies, including vacuum-based and fluid-based systems like the Quatera 700, impact surgical efficiency and chamber stability during cataract procedures, emphasizing the importance of optimized fluidics settings for safe outcomes.


Oluwatosin U. Smith, MD

Latest:

ASCRS 2025: Oluwatosin U. Smith, MD, champions early intervention and innovative glaucoma technologies

Explore innovative glaucoma treatments and technologies, including AI, home monitoring, and new surgical options, to enhance patient care.


Radhika Rampat, MBBS, FRCOphth

Latest:

Standardizing terminology for clarity in refractive surgery

Language can drive understanding, trust, and better outcomes for patients


Ferhina Ali, MD, MPH

Latest:

ARVO 2025: Aflibercept 8mg in treatment-naive AMD

At ARVO 2025, in Salt Lake City, Utah, Ferhina Ali, MD, MPH, talked about her presentation on the early real-world use of aflibercept 8 mg in treatment-naive patients with neovascular age-related macular degeneration


T.Y. Alvin Liu, MD

Latest:

Clearing hurdles to large scale telemedicine adoption

During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye


R.V. Paul Chan, MD

Latest:

Partners collaborate on integration of AI-supported ROP telemedicine globally

Siloam Vision and Orbis team up to develop infrastructure to save the vision of premature infants.


Jibran Sharieff, MD

Latest:

Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)

In this final episode, DMEI’s residents share their future plans for expanding the device capabilities and offer practical advice to other up-and-coming creators in eye care technology.


Mark Milner
Mark S. Milner, MD

Latest:

The benefits of cryopreserved amniotic membrane during COVID-19

CAM’s regenerative healing means long-term relief and fewer visits to clinic.



Larry Hanover

Latest:

The untapped potential of cell and gene therapy as treatment option

Investigators continue to break new ground, giving hope to patients, physicians.


Lucy Shen, MD

Latest:

EnVision Summit 2025: Complications in glaucoma surgery

At the EnVision Summit 2025 in San Juan, Puerto Rico, Tania Tai, Lucy Shen, and Shivani Kamat all gave insight into complications they have seen while performing glaucoma surgery.


Amy Zhang, MD

Latest:

EnVision Summit 2025: Ergonomics in the operating room

At the Envision Summit 2025 in San Juan, Puerto Rico, Amy Zhang, MD, discussed the importance of ergonomics in the operating room.


Caesar K. Luo, MD, FACS, FASRS

Latest:

Durable therapies for diabetic macular edema amid COVID-19 pandemic

Patients’ reluctance to visit a clinic during the COVID-19 pandemic is pushing retina specialists to optimize therapy.


Hattie Hayes

Latest:

ARVO 2025: Lipid metabolism altered by CFH (Y402H) polymorphism and chronic oxidative stress in iPSC-derived RPE cells

At ARVO 2025, in Salt Lake City, Utah, Peng Shang, PhD, talked about her presentation on how the Y402H polymorphism of Complement Factor H (CFH), a major genetic risk factor for AMD, and chronic oxidative stress affect the lipid profile of retinal pigment epithelial (RPE) cells.


Júlia Jiquilin Carvalho, MD

Latest:

The evolving role of vitreosurgical simulators in surgical training

Need to eliminate errors results in optimization of training of novice surgeons.


Jorge L. Alió, MD, PhD, FEBO

Latest:

Cosmetic surgery of the cornea: A new type of surgery

Keratopigmentation technique offers therapeutic and cosmetic applications.


John Tan

Latest:

ARVO 2025: Walk through a novel triaging framework for emergent retinal pathologies

Researchers stratified a dataset of more than 100 patients in an emergency department to see which patients may be indicated for retinal artery occlusions.


Adam Wenick, MD, PhD

Latest:

EyeCon 2024: Myopia interventions across the lifespan

Adam S. Wenick, MD, PhD, discussed myopia interventions across the lifespan at EyeCon 2024, covering treatments, complications, and prevention strategies.



T. Y. Alvin Liu, MD

Latest:

Ophthalmology sees AI-powered impact on cataract and diabetic eye disease

Shameema Sikder, MD; and T. Y. Alvin Liu, MD, highlight the technology’s role in bridging challenges and successes for clinical practice.


Refractive Surgery Council

Latest:

Laser vision correction procedures soar in wake of COVID-19

According to the Refractive Surgery Council, patients continue to have a high level of interest in laser vision correction procedures.


Kelly Donovan, MD

Latest:

Envision Summit 2025: Understanding hyperglycemia in diabetic retinopathy

At the Envision Summit 2025 in San Juan, Puerto Rico, Kelly Donovan, MD, talked about her graduate research on the earliest phase of diabetic retinopathy, and trying to understand how hyperglycemia translates into disease.


Mackenzie Andrews

Latest:

Blog: A call to stop discarding eye medications after a single use or before expiration date

In a blog, Mackenzie Andrews, the CCO and a co-founder of Nanodropper, discusses the need to update policies on single-use and early disposal of eyedrops.


Daniel S. Choi, MD

Latest:

Recent changes to cornea: Preferred Practice Patterns

A Q&A with PPP Committee Cornea/External Disease Panel member Daniel S. Choi, MD.


Evangelia Gkaragkani, MD

Latest:

Preserving patients’ vision by monitoring glaucoma progression rate

Three approaches to examination provide a comprehensive overview


© 2025 MJH Life Sciences

All rights reserved.